(Q40791217)

23 September 2017

Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms (English)

1 reference

Crossref

DOI

10.1001/JAMA.238.9.943

https://api.crossref.org/works/10.1001/JAMA.238.9.943

22 March 2023

0 references

1 reference

V. L. Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A328950

22 March 2023

F. S. Rhame

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A328950

22 March 2023

E. L. Pesanti

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A328950

22 March 2023

S. G. Axline

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A328950

22 March 2023

language of work or name

English

0 references

publication date

1 August 1977

1 reference

23 September 2017

29 August 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=328950

The Journal of the American Medical Association

22 March 2023

published in

1 reference

23 September 2017

238

1 reference

23 September 2017

9

1 reference

23 September 2017

943-947

1 reference

10.1001/JAMA.1977.03280100027017

23 September 2017

Identifiers

DOI

1 reference

23 September 2017

10.1001/JAMA.238.9.943

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=328950

22 March 2023

1 reference